United States Ninth Circuit
BROUDO v. DURA PHARMS., INC., 01-57136
A complaint satisfied the loss causation element of a Section 10(b) violation of the Securities and Exchange Act of 1934 with respect to a device for asthma medication delivery, and the district court abused its discretion in not permitting plaintiffs to amend the complaint to include additional allegations regarding antibiotic sales.
Appellate Information
- Argued 02/04/2003
- Decided 08/05/2003
- Published 08/05/2003
Judges
- ARCHER, Senior Circuit Judge., Before PREGERSON, REINHARDT, and ARCHER, Circuit Judges.
Court
- United States Ninth Circuit
Counsel
- For Appellant:
- William S. Lerach,Jan M. Adler, Eric A. Isaacson, Henry Rosen, Tor Gronborg, Joseph D. Daley, Milberg Weiss Bershad Hynes & Lerach LLP, Alan Schulman, Blair A. Nicholas, Bernstein Litowitz Berger & Grossmann, LLP, San Diego, CA; Steven J. Toll, Cohen, Milstein, Hausfeld & Toll, P.L.L.C., Seattle, WA, for the plaintiffs-appellants.
- For Appellees:
- William F. Sullivan, Christopher H. McGrath, Sean T. Prosser, Colleen E. Huschke, Brobeck, Phleger & Harrison, LLP, San Diego, CA, for the defendants-appellees.